Organophosphate-induced delayed polyneuropathy

Marcello Lotti1, Angelo Moretto

  • 1Department of Environmental Medicine and Public Health, University of Padua, Padova, Italy. marcello.lotti@unipd.it

Toxicological Reviews
|July 27, 2005
PubMed

Insights

Organophosphate-induced delayed polyneuropathy (OPIDP) is a rare nerve condition caused by certain organophosphorus esters. It leads to progressive weakness and sensory loss weeks after exposure, with potential for long-term effects.

Area of Science:

  • Neurotoxicology
  • Environmental Health
  • Occupational Medicine

Background:

  • Organophosphate-induced delayed polyneuropathy (OPIDP) is a distinct neurological disorder.
  • It results from exposure to specific organophosphorus (OP) esters, often encountered in pesticides and industrial chemicals.
  • OPIDP is characterized by axonal degeneration in the peripheral and central nervous systems, typically manifesting 1-4 weeks post-exposure.

Purpose of the Study:

  • To review the clinical manifestations, electrophysiological findings, and pathological characteristics of OPIDP.
  • To discuss the mechanism of OPIDP, focusing on the role of neuropathy target esterase (NTE) inhibition.
  • To differentiate OPIDP caused by OP pesticides from that caused by non-pesticidal OP compounds, such as triaryl phosphates.

Main Methods:

  • Review of human and experimental data on OPIDP.
  • Analysis of clinical case reports and observational studies.
  • Discussion of toxicological principles, including the ratio of inhibitory powers for acetylcholinesterase and NTE.

Main Results:

  • OPIDP presents with distal sensory and motor disturbances, including pain, numbness, weakness, and gait abnormalities.
  • Electrophysiological studies show reduced nerve excitability and axonal degeneration, with nerve biopsies revealing secondary demyelination.
  • Non-pesticidal triaryl phosphates, like tri-ortho-cresyl phosphate, have caused more widespread OPIDP than OP insecticides.
  • Specific OP pesticides like chlorpyrifos and dichlorvos are discussed as potential causes.

Conclusions:

  • OPIDP is a serious neurological outcome of exposure to certain OP compounds, with varying etiological agents.
  • The ratio of inhibition of acetylcholinesterase versus NTE is critical for understanding OP-induced neuropathies.
  • While recovery is possible, severe cases can lead to permanent neurological deficits, particularly spastic ataxia.

Related Concept Videos

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Indirect-Acting Cholinergic Agonists: Pharmacokinetics01:22

Indirect-Acting Cholinergic Agonists: Pharmacokinetics

Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Botulism01:22

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...